Enhancing Exosome Production from Adipose-Derived Stem Cells via Arachidonic Acid Priming for Diabetic Wound Healing
- 1Department of Plastic and Reconstructive, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China
Abstract
Adipose-derived stem cell (ADSC)-derived exosomes are promising for regenerative therapy. However, their clinical translation is hindered by limited secretion yield and reduced functional potency. Here, we tested whether arachidonic acid (AA) priming increases exosome production while preserving exosomal identity, and whether AA-primed exosomes (AA-Exos) enhance diabetic wound repair. ADSCs were treated with AA, and exosome yield was quantified using particle counts and cumulative acetylcholinesterase (AChE) activity. Exosome morphology and canonical markers were assessed to confirm identity. Mechanistically, transcriptomic and functional analyses revealed that AA promoted multivesicular body and intraluminal vesicle formation through CHMP1B upregulation and facilitated exosome release through Rab27b, and knockdown of either gene impaired the corresponding process. Proteomic profiling further showed that AA-Exos were enriched in wound-repair-related cargo, particularly interleukin-8 (IL-8/CXCL8). In high-glucose-challenged endothelial cells, AA-Exos enhanced proliferation and migration and reduced apoptosis by activating FAK/AKT/ERK signaling, whereas IL-8 neutralization attenuated these effects. In a diabetic mouse model, AA-Exos accelerated wound closure and improved tissue perfusion, angiogenesis, and collagen deposition. Taken together, AA priming enhances exosome production while improving their therapeutic function, suggesting a practical strategy to strengthen the translational potential of ADSC-derived exosomes for diabetic wound regeneration.
Related
- Adipose-derived stem cell-derived extracellular vesicles promote critical-sized bone defect repair by enhancing the homing of bone marrow mesenchymal stem cells
- Adipose-derived stem cell extracellular vesicles in diabetic microangiopathy: from pathological networks to clinical translation
- Adipose-derived stem cell-derived exosomes suppress NLRP3 inflammasome-mediated microglial pyroptosis by activating the Nrf2/HO-1 pathway to protect against retinal ganglion cell injury in diabetic retinopathy
- Identification, functional characterization of a novel flavohemoglobin from Ensifer adhaerens and its application to enhancing vitamin B₁₂ production.
- Flocculent Ti3AlC2-Based Two-Dimensional Material Flexible Microneedle Patch for Screening Alzheimer’s Disease Animal Biomarkers and In Situ Revealing Spatial Aggregation of Arachidonic Acid
BibTeX
@article{cai2026enhancing,
title = {{Enhancing Exosome Production from Adipose-Derived Stem Cells via Arachidonic Acid Priming for Diabetic Wound Healing}},
author = {Yujiao Cai and Jinnan Wang and Ruobing Zhang and Dehui Che and Juan Xie and Dongsheng Cao},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = oct,
doi = {10.3390/ijms27209029},
url = {https://www.mdpi.com/1422-0067/27/20/9029},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Enhancing Exosome Production from Adipose-Derived Stem Cells via Arachidonic Acid Priming for Diabetic Wound Healing
AU - Yujiao Cai
AU - Jinnan Wang
AU - Ruobing Zhang
AU - Dehui Che
AU - Juan Xie
AU - Dongsheng Cao
PY - 2026
DA - 2026/10/12
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms27209029
UR - https://www.mdpi.com/1422-0067/27/20/9029
AB - Adipose-derived stem cell (ADSC)-derived exosomes are promising for regenerative therapy. However, their clinical translation is hindered by limited secretion yield and reduced functional potency. Here, we tested whether arachidonic acid (AA) priming increases exosome production while preserving exosomal identity, and whether AA-primed exosomes (AA-Exos) enhance diabetic wound repair. ADSCs were treated with AA, and exosome yield was quantified using particle counts and cumulative acetylcholinesterase (AChE) activity. Exosome morphology and canonical markers were assessed to confirm identity. Mechanistically, transcriptomic and functional analyses revealed that AA promoted multivesicular body and intraluminal vesicle formation through CHMP1B upregulation and facilitated exosome release through Rab27b, and knockdown of either gene impaired the corresponding process. Proteomic profiling further showed that AA-Exos were enriched in wound-repair-related cargo, particularly interleukin-8 (IL-8/CXCL8). In high-glucose-challenged endothelial cells, AA-Exos enhanced proliferation and migration and reduced apoptosis by activating FAK/AKT/ERK signaling, whereas IL-8 neutralization attenuated these effects. In a diabetic mouse model, AA-Exos accelerated wound closure and improved tissue perfusion, angiogenesis, and collagen deposition. Taken together, AA priming enhances exosome production while improving their therapeutic function, suggesting a practical strategy to strengthen the translational potential of ADSC-derived exosomes for diabetic wound regeneration.
SN - 1422-0067
ER -